Talk to a Concierge  →
Home  ›  Related Resources  ›  Beijing Jishuitan Hospital  ›  Elbow fixator development
Treatment Innovation · English Editorial Summary

A self-developed internal fixator moves the elbow’s external frame inside the body

Jishuitan Hospital's elbow team reports treating two patients with long-standing elbow fracture-dislocations using a patented internal fixator designed to replace the painful hinged external frames used in the past. Two cases, not yet a marketed product.

Original report: 20 May 2026English summary: 30 May 2026Source: Beijing Municipal Health Commission websiteEdited by Wellward China
Beijing Jishuitan HospitalBeijingBones, Joints, Spine & MusclesElbow dislocationInternal fixatorLigament reconstructionMedical device innovation
Source and editorial note: This is an original English summary based on the Beijing Municipal Health Commission's relay of the hospital's Chinese-language report, published 20 May 2026. It is not a full translation or an independent clinical assessment. The hospital's source is the authority for the original announcement.
The development

Moving the frame inside the elbow

A chronic elbow dislocation or fracture-dislocation — one that is more than two weeks old — is one of the genuinely difficult problems in orthopaedics. By that stage the joint is filled with adhesions, tendons are shortened, and fractures have healed in the wrong position. Treatment has traditionally relied on hinged external fixators: frames that sit outside the arm for weeks or months. They work mechanically, but they are painful, pin-site care is demanding, and they interfere badly with daily life.

The elbow team at Beijing Jishuitan Hospital — Professor Jiang Xieyuan, the hospital's president and China's leading elbow specialist, together with Professor Cha Yejun — reports treating two patients with a self-developed internal elbow fixator: essentially, the hinged frame moved to the inside of the body, paired with a rotation-centre targeting guide for accurate placement.

The two reported cases

The first patient was a 40-year-old woman left with an unstable, weak elbow after limb-salvage surgery for an open, near-amputation injury; several hospitals had been unable to help. On 2 April 2026 the team performed ligament reconstruction with internal fixator implantation. At her 40-day review she had fully recovered her range of motion and stability — better than the team expected.

The second was a 51-year-old woman whose elbow had been fractured and dislocated for nearly a year and sat locked almost straight, with an old radial head fracture. On 13 April 2026 she underwent a single-stage reconstruction: release of the stiff joint, reduction of the old dislocation, triceps lengthening, ulnar nerve release, radial head replacement, ligament repair and internal fixator implantation, followed by three weeks of protection. Thirty days after surgery, one week out of her brace, she had regained a good bend and a stable joint, with no implant irritation.

Evidence status: two case reports and a patent portfolio

Two successfully treated patients demonstrate feasibility, not effectiveness at scale. The hospital states that the internal fixator and the rotation-centre targeting guide are covered by multiple patents, that technology transfer has been completed, and that the product will reach the market only after full clinical research is finished. It is not currently a standard, available option.

Why the approach matters

For decades the surgical answer to chronic elbow instability has been "apply a hinge outside the arm and wait". An internal hinge that spares patients the external frame addresses the part of this treatment patients hate most. If subsequent clinical research confirms the early experience, it would be a meaningful option for a condition with few good answers anywhere in the world.

Relevance to elbow injury patients

Chronic elbow instability and stiffness after old injuries are among the problems international patients travel for, and Jishuitan's elbow unit is among the largest anywhere. International patients should read this as a research development to ask about, not an available implant: the device is not yet on the market. This summary belongs to the Bones, Joints, Spine & Muscles health area.